Investors / Licensing out

IPSS is actively accepting requests from investors or venture capital groups that wish to maximize and/or diversify their portfolio by investing in innovative, profitable drug products, technologies and patents. Alternatively, IPSS is open to licensing partners interested in commercializing its drug products and projects under development (including Siosomes ® technology and/or ELPIS 207 patent). Please contact us via email at info@ipss-consulting.com.